Susquehanna International Group
OCRX

Susquehanna International Group’s Ocera Therapeutics, Inc. OCRX Stock Holding History

Susquehanna International Group’s Portfolio OCRX Stock Details OCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-34,751
Closed -$73K – 10678
2016
Q4 		$73K Buy
+34,751
New +$81.1K ﹤0.01% 9196
2014
Q3 		– Sell
-24,460
Closed -$187K – 10303
2014
Q2 		$187K Sell
24,460
-2,537
-9% -$20.2K ﹤0.01% 9122
2014
Q1 		$285K Buy
+26,997
New +$386K ﹤0.01% 7668

Other funds holding OCRX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group's OCRX Position: Q1 2017 in Review

Susquehanna International Group sold out of Ocera Therapeutics, Inc. (OCRX) in Q1 2017, closing a stake of 34,751 shares — an estimated $73K sold.

Susquehanna International Group first reported a position in OCRX in Q1 2014 and held it in 3 quarters. The position peaked at $285K in Q1 2014. 26 funds tracked by Wall St. Rank hold OCRX as of Q1 2017.

  • Susquehanna International Group reported no remaining Ocera Therapeutics, Inc. position as of Q1 2017 after selling out during the quarter.
  • Susquehanna International Group sold 34,751 Ocera Therapeutics, Inc. shares in Q1 2017, an estimated $73K.
  • Susquehanna International Group first reported a position in Ocera Therapeutics, Inc. in Q1 2014 and held it in 3 quarters.
  • Susquehanna International Group's Ocera Therapeutics, Inc. position peaked at $285K in Q1 2014.
  • 26 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q1 2017.

Based on Susquehanna International Group's 13F filing for Q1 2017, filed 15 May 2017.